Jennifer L. Brooks

1.5k citations

23 papers · 997 indexed · h-index 14

Co-authors: Gregg Timony Robert Peach Marcus F. Boehm Hugh Rosen Amanda B. Nickerson Martha Zaslow Enugurthi Brahmachary Fiona L. Scott
Topics: Sphingolipid Metabolism and Signaling (7 papers)HIV/AIDS drug development and treatment (6 papers)Biochemical and Molecular Research (4 papers)
Cited by: Hepatology Safety Research Infectious Diseases
Journals: Journal of Biological Chemistry Gastroenterology Neurology
Partner nations: United States Switzerland Germany

In The Last Decade

Jennifer L. Brooks

22 papers receiving 917 citations

Peers

Countries citing papers authored by Jennifer L. Brooks

Since Specialization

Citations

This map shows the geographic impact of Jennifer L. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer L. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer L. Brooks more than expected).

Fields of papers citing papers by Jennifer L. Brooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer L. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer L. Brooks. The network helps show where Jennifer L. Brooks may publish in the future.

Co-authorship network of co-authors of Jennifer L. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer L. Brooks. A scholar is included among the top collaborators of Jennifer L. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer L. Brooks. Jennifer L. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator 2021 ·Drug Metabolism and Disposition ·Sekhar Surapaneni,Usha Yerramilli,(unknown),Deepak Dalvie,Jennifer L. Brooks,Xiaomin Wang,Julie V. Selkirk,Yingzhuo Yan,Peijin Zhang,Richard Hargreaves,Gondi Kumar,Maria Palmisano,Jonathan Q. Tran	56
2	Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator 2017 ·The Journal of Clinical Pharmacology ·Jonathan Q. Tran,Jeffrey Hartung,Robert Peach,Marcus F. Boehm,Hugh Rosen,Heather Smith,Jennifer L. Brooks,Gregg Timony,Allan Olson,Sheila Gujrathi,Paul Frohna	87
3	Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P ₁ ) and receptor‐5 (S1P ₅ ) agonist with autoimmune disease‐modifying activity 2016 ·British Journal of Pharmacology ·Fiona L. Scott,Bryan Clemons,Jennifer L. Brooks,Enugurthi Brahmachary,Rachel Powell,Harry Dedman,(unknown),Gregg Timony,Esther Martinborough,Hugh Rosen,Edward Roberts,Marcus F. Boehm,Robert Peach	239
4	Safety and Tolerability of Orally Administered RPC1063, a Novel S1P1 Receptor Modulator, in Healthy Adult Volunteers, Results of a Phase 1 Study (P01.178) 2013 ·Neurology ·Allan Olson,Jeffrey Hartung,Gregg Timony,Robert Peach,Marcus F. Boehm,Hugh Rosen,Heather Smith,(unknown),Jennifer L. Brooks,Sheila Gujrathi	5
5	Metabolites of RPC1063 Contribute to In Vivo Efficacy (P05.157) 2013 ·Neurology ·Fiona L. Scott,Gregg Timony,Jennifer L. Brooks,Robert Peach,Bryan Clemons,(unknown),M. N. Moorjani,(unknown),Rachel Powell,Harry Dedman,Esther Martinborough,Marcus F. Boehm	4
6	Sa1222 Results of a Safety and Tolerability Study of Rpc1063, a Novel Orally Administered Sphingosine-1-Phosphate Receptor 1 (S1p1r) Agonist, in Healthy Adult Volunteers 2013 ·Gastroenterology ·Allan Olson,Gregg Timony,Jeffrey Hartung,Heather Smith,Robert Peach,Hugh Rosen,(unknown),Jennifer L. Brooks,Marcus F. Boehm,Sheila Gujrathi	2
7	Sa1221 Rpc1063, a Potent, Selective S1P1 Receptor Modulator, Is Active in a Therapeutic IBD Model and Exhibits Favorable PK/PD Properties in Healthy Volunteers 2013 ·Gastroenterology ·Jennifer L. Brooks,Robert Peach,Marcus F. Boehm,Enugurthi Brahmachary,Bryan Clemons,Harry Dedman,(unknown),Sheila Gujrathi,Li‐Min Huang,Jeffrey Hartung,Esther Martinborough,M. N. Moorjani,Rachel Powell,Greg J. Reinhart,Fiona L. Scott,(unknown),(unknown),Hugh Rosen,Gregg Timony	3
8	Development of an injectable two‐phase drug delivery system for sequential release of antiresorptive and osteogenic drugs 2011 ·Journal of Biomedical Materials Research Part B Applied Biomaterials ·Yuan Zou,Jennifer L. Brooks,Vishwas Talwalkar,Todd A. Milbrandt,David A. Puleo	23
9	Transitioning Youth from Residential Treatment to the Community: A Preliminary Investigation 2007 ·Child & Youth Care Forum ·Amanda B. Nickerson,(unknown),Jennifer L. Brooks,(unknown),(unknown)	28
10	Family Involvement in Residential Treatment: Staff, Parent, and Adolescent Perspectives 2006 ·Journal of Child and Family Studies ·Amanda B. Nickerson,Jennifer L. Brooks,(unknown),(unknown),(unknown)	30
11	2′,3′-Dideoxynucleoside 5′-β,γ-(Difluoromethylene) Triphosphates With α-P-Thio or α-P-Seleno Modifications: Synthesis and Their Inhibition of HIV-1 Reverse Transcriptase 2005 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown),Patrick Fagan,Jennifer L. Brooks,Marija Prhavc,John S. Lambert,P. Dan Cook	10
12	Synthesis of 5′-Triphosphate Mimics (P3Ms) of 3′-Azido-3′,5′-Dideoxythymidine and 3′,5′-Dideoxy-5′-Difluoromethylenethymidine as HIV-1 Reverse Transcriptase Inhibitors 2005 ·Nucleosides Nucleotides & Nucleic Acids ·Vivek K. Rajwanshi,Marija Prhavc,Patrick Fagan,Jennifer L. Brooks,(unknown),P. Dan Cook,Guangyi Wang	5
13	THE ESTIMATED EFFECT OF MATERNAL EMPLOYMENT ON CHILDREN UNDER MANDATORY AND NON-MANDATORY EMPLOYMENT CIRCUMSTANCES 2005 ·Community Work & Family ·Sharon M. McGroder,Martha Zaslow,Angela Romano Papillo,(unknown),Jennifer L. Brooks	4
14	Synthesis of 2‘,3‘-Dideoxynucleoside 5‘-α-P-Borano-β,γ-(difluoromethylene)triphosphates and Their Inhibition of HIV-1 Reverse Transcriptase 2005 ·Journal of Medicinal Chemistry ·(unknown),Vivek K. Rajwanshi,Marija Prhavc,Guangyi Wang,Patrick Fagan,Fu Chen,Gregory J. Ewing,Jennifer L. Brooks,(unknown),Janet M. Leeds,Thomas W. Bruice,P. Dan Cook	28
15	Promising Approaches to Engaging Families and Building Strengths in Residential Treatment 2004 ·Residential Treatment for Children & Youth ·Amanda B. Nickerson,(unknown),Jennifer L. Brooks,(unknown)	38
16	Synthesis of AZT 5‘-Triphosphate Mimics and Their Inhibitory Effects on HIV-1 Reverse Transcriptase 2004 ·Journal of Medicinal Chemistry ·Guangyi Wang,Nicholas Boyle,Chen Fu,(unknown),Patrick Fagan,Jennifer L. Brooks,(unknown),Janet M. Leeds,Vivek K. Rajwanshi,Yi Jin,Marija Prhavc,Thomas W. Bruice,P. Dan Cook	53
17	Experimental studies of welfare reform and children. 2002 ·PubMed ·Martha Zaslow,Kristin Anderson Moore,Jennifer L. Brooks,Pamela Morris,Kathryn Tout,Zakia Redd,(unknown)	75
18	Welfare Reform's Impact on Adolescents: Early Warning Signs. Child Trends Research Brief. 2001 ·Jennifer L. Brooks,Elizabeth C. Hair,Martha Zaslow	23
19	Light-Induced Spectral Changes in Fully Oxidized Cytochrome c Oxidase in the Presence of Oxygen 1997 ·Biochemistry ·Jennifer L. Brooks,Artur Sucheta,Ólöf Einarsdóttir	13
20	The Pleckstrin Homology Domain in Insulin Receptor Substrate-1 Sensitizes Insulin Signaling 1995 ·Journal of Biological Chemistry ·Martin G. Myers,Timothy C. Grammer,Jennifer L. Brooks,Erin Glasheen,Ling-Mei Wang,Xiao‐Jian Sun,John Blenis,Jacalyn H. Pierce,Morris F. White	105

About Jennifer L. Brooks

Jennifer L. Brooks is a scholar working on Safety Research, Infectious Diseases and Gender Studies, having authored 23 papers that have together received 997 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (7 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Hepatology (108 citations), Safety Research (97 citations) and Infectious Diseases (174 citations). Jennifer L. Brooks has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Gregg Timony, Robert Peach, Marcus F. Boehm, Hugh Rosen, Amanda B. Nickerson, Martha Zaslow, Enugurthi Brahmachary, Fiona L. Scott, Rachel Powell and Esther Martinborough. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact